Kehua Biotech (002022.SZ): “Lipoprotein (a) Determination Kit (Latex Immune Turbidimetry)” obtained a medical device registration certificate

Gelonghui Finance ·  05/09/2023 17:55

Gelonghui May 9th 丨Kehua Biology (002022.SZ) announced that recently, Shanghai Kehua Bioengineering Co., Ltd. received the “Medical Device Registration Certificate” (in vitro diagnostic reagent) issued by the Shanghai Drug Administration. It is a lipoprotein (a) test kit (latex immunization turbidity method).

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment